SynBio-SynChem Approaches to Diversifying the Pacidamycins through the Exploitation of an Observed Pictet-Spengler Reaction
| dc.contributor.author | Cartmell, Christopher | |
| dc.contributor.author | Abou Fayad, Antoine G. | |
| dc.contributor.author | Lynch, Rosemary | |
| dc.contributor.author | Sharma, Sunil Vishnuprasadji | |
| dc.contributor.author | Hauck, Nils | |
| dc.contributor.author | Gust, Bertolt | |
| dc.contributor.author | Goss, Rebecca J.M. | |
| dc.contributor.department | Experimental Pathology, Microbiology, and Immunology | |
| dc.contributor.faculty | Faculty of Medicine (FM) | |
| dc.contributor.institution | American University of Beirut | |
| dc.date.accessioned | 2025-01-24T11:39:06Z | |
| dc.date.available | 2025-01-24T11:39:06Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | A nonenzymatic Pictet-Spengler reaction has been postulated to give rise to a subset of naturally occurring uridyl peptide antibiotics (UPAs). Here, using a combination of strain engineering and synthetic chemistry, we demonstrate that Pictet-Spengler chemistry may be employed to generate even greater diversity in the UPAs. We use an engineered strain to afford access to meta-tyrosine containing pacidamycin 4. Pictet-Spengler diversification of this compound using a small series of aryl-aldehydes was achieved with some derivatives affording remarkable diastereomeric control. © 2020 The Authors. ChemBioChem published by Wiley-VCH GmbH | |
| dc.identifier.doi | https://doi.org/10.1002/cbic.202000594 | |
| dc.identifier.eid | 2-s2.0-85099446862 | |
| dc.identifier.pmid | 33058439 | |
| dc.identifier.uri | http://hdl.handle.net/10938/29176 | |
| dc.language.iso | en | |
| dc.publisher | Wiley-VCH Verlag | |
| dc.relation.ispartof | ChemBioChem | |
| dc.source | Scopus | |
| dc.subject | Compound diversification | |
| dc.subject | Natural products | |
| dc.subject | Pacidamycin | |
| dc.subject | Pictet-spengler | |
| dc.subject | Semisynthesis | |
| dc.subject | Uridyl peptide antibiotic | |
| dc.subject | Anti-bacterial agents | |
| dc.subject | Oligopeptides | |
| dc.subject | Peptides | |
| dc.subject | Streptomyces | |
| dc.subject | Uridine | |
| dc.subject | Pacidamycin 4 | |
| dc.subject | Polypeptide antibiotic agent | |
| dc.subject | Tetrahydroisoquinoline | |
| dc.subject | Unclassified drug | |
| dc.subject | Antiinfective agent | |
| dc.subject | Oligopeptide | |
| dc.subject | Peptide | |
| dc.subject | Amino terminal sequence | |
| dc.subject | Article | |
| dc.subject | Bacterial strain | |
| dc.subject | Bacterium culture | |
| dc.subject | Diastereoisomer | |
| dc.subject | Diastereoselectivity | |
| dc.subject | Drug synthesis | |
| dc.subject | Fermentation | |
| dc.subject | Gene | |
| dc.subject | Gene cluster | |
| dc.subject | Gene control | |
| dc.subject | Horizontal gene transfer | |
| dc.subject | Ion exchange | |
| dc.subject | Liquid chromatography-mass spectrometry | |
| dc.subject | Mic90 | |
| dc.subject | Nonhuman | |
| dc.subject | Npsm gene | |
| dc.subject | Nuclear magnetic resonance spectroscopy | |
| dc.subject | Pictet spengler reaction | |
| dc.subject | Plasmid | |
| dc.subject | Priority journal | |
| dc.subject | Proton nuclear magnetic resonance | |
| dc.subject | Pseudomonas aeruginosa | |
| dc.subject | Reversed phase liquid chromatography | |
| dc.subject | Streptomyces coeruleorubidus | |
| dc.subject | Metabolism | |
| dc.subject | Synthesis | |
| dc.title | SynBio-SynChem Approaches to Diversifying the Pacidamycins through the Exploitation of an Observed Pictet-Spengler Reaction | |
| dc.type | Article |
Files
Original bundle
1 - 1 of 1